Document Detail


Clinical management and diagnostic possibilities in hydatidiform mole with coexistent fetus.
MedLine Citation:
PMID:  1720883     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The goal of the current review is to present the figures essential for counseling, when hydatidiform mole and normal fetus occur together. Previous reviews of prognosis and risks when mole and fetus are observed together did not adjust for differences in genetic constitution and thus varying risks for gynecologic and obstetric complications. A literature search from 1903 to 1989 revealed 113 reports of pregnancies with mole and fetus in which there appeared to be no major malformations or cytogenetic abnormalities; 87 of those were intended to continue. This group provides the most appropriate risk figures, when mole and karyotypically normal child are detected by first or second trimester prenatal diagnosis. Fifty-two pregnancies (59.8 per cent) proceeded to the 28th week without spontaneous abortion or interruption of pregnancy. None of the children delivered before week 28 survived. Of the pregnancies continuing beyond this time 69.2 per cent of the children survived, 7.7 per cent were live-born with unknown long-term outcome, 17.3 per cent died neonatally, and 5.8 per cent succumbed before delivery. Persistent trophoblastic disease was reported in 19.2 per cent of pregnancies interrupted at diagnosis, as well as in 9.1 per cent of those intended to continue. Due to advances in prenatal diagnosis, clinicians will be confronted with counseling in pregnancies with mole and fetus more often than expected from the literature. Chorionic villus biopsy or amniocentesis can disclose those triploid gestations without possibility of a surviving child. First trimester ultrasound demonstration of a partially cystic placenta and abnormal high se-hCG values should initiate prenatal diagnosis for evaluation of the fetal karyotype, before deciding whether to abort or continue the pregnancy.
Authors:
L O Vejerslev
Related Documents :
7078853 - Partial moles: a clinicopathologic study of 25 cases.
2107033 - Effects of brain microtubule-associated proteins on microtubule dynamics and the nuclea...
2384353 - Effect of location and season on body and testicular growth in brahman and hereford bulls.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Obstetrical & gynecological survey     Volume:  46     ISSN:  0029-7828     ISO Abbreviation:  Obstet Gynecol Surv     Publication Date:  1991 Sep 
Date Detail:
Created Date:  1992-01-10     Completed Date:  1992-01-10     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0401007     Medline TA:  Obstet Gynecol Surv     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  577-88     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Hvidovre Hospital, University of Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chorionic Gonadotropin / blood
Female
Fetus*
Humans
Hydatidiform Mole / diagnosis*,  genetics
Karyotyping
Magnetic Resonance Imaging
Pregnancy
Pregnancy Complications
Pregnancy Outcome
Prenatal Care* / methods
Prenatal Diagnosis*
Ultrasonography, Prenatal
Uterine Neoplasms / diagnosis*,  genetics
alpha-Fetoproteins / metabolism
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/alpha-Fetoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neuro...
Next Document:  Coagulation disorders and tumor markers in the diagnosis of pancreatic cancer.